News
- Author:
- Andrew D. Bowser
Publish date: May 15, 2019
“We recommend that doctors’ mentors, supervisors, peers, and occupational health support services recognize and act on the prevalence of occupation...
News
- Author:
- Andrew D. Bowser
Publish date: May 14, 2019
PHILADELPHIA – Primary endpoint of reducing enhancing lesions versus placebo was met with evobrutinib.
News
- Author:
- Andrew D. Bowser
Publish date: May 14, 2019
PHILADELPHIA – Relapse rate and radiographic endpoints significantly improved with the 0.5-mg daily dose of fingolimod, with safety as expected bas...
News
- Author:
- Andrew D. Bowser
Publish date: May 13, 2019
PHILADELPHIA - A positive risk-to-benefit ratio over nearly 1 year for the anti-CD20 monoclonal antibody.
News
- Author:
- Andrew D. Bowser
Publish date: May 11, 2019
PHILADELPHIA – Interim results of an open-label study suggest that changes in AIMS score are at least maintained over the course of nearly 3 years....
News
- Author:
- Andrew D. Bowser
Publish date: May 10, 2019
PHILADELPHIA – A free app and online calculator are available to calculate the four-item ‘CoRisk’ score.
News
- Author:
- Andrew D. Bowser
Publish date: May 10, 2019
PHILADELPHIA – The diagnostic importance of “dystextia” is more important now than ever given the ubiquity of smartphones.
News
- Author:
- Andrew D. Bowser
Publish date: May 8, 2019
Vaccine effectiveness was high in children with laboratory-confirmed rotavirus infection, although effects on all-cause gastroenteritis could not b...
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
PHILADELPHIA – Nearly 98% of patients with this autoimmune inflammatory CNS disorder were relapse-free at 48 weeks in the randomized phase 3 PREVEN...
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
Serious complications and death are likely if Fournier gangrene is not recognized.
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
PHILADELPHIA –Rivaroxaban was more often than other DOACs associated with events in nonvalvular atrial fibrillation patients, based on a small stud...
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
PHILADELPHIA – Donor-derived T cells seen as having “potential to be one of the first effective treatments for PML.”
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
PHILADELPHIA – Experimental treatment may benefit adolescents and adults with Angelman syndrome.
News
- Author:
- Andrew D. Bowser
Publish date: May 6, 2019
But emergency department visits related to opioids increased in new adopters of direct authority laws.
News
- Author:
- Andrew D. Bowser
Publish date: May 4, 2019
Formal palliative care training was lacking among the physicians surveyed.
